
































































Molecularand HistologicalProfiling Reveals an Innate-




INTRODUCTION: S o lita ry ju v e n ile p o ly p s (J P ) a re c h a ra c te riz e d b y a b e n ig n d is e a s e c o u rs e with lo w re c u rre n c e ra te b u t
p re s e n t with s ig n s o f in te s tin a l in fla mma tio n . T o b e tte r u n d e rs ta n d th e u n d e rly in g p a th o g e n e s is , we
p e rfo rme d h is to lo g ic a l a n d mo le c u la r e v a lu a tio n ta rg e tin g d is tin c t immu n e me c h a n isms.
METHODS: P e d ia tric p a tie n ts with J P (n 5 1 2 ), with tre a tme n t-n a ı̈v e in fla mma to ry b o we l d is e a s e (IBD; [n 5 4 1 ])
a s in fla mma to ry c o n tro l, a n d n o n -IBD c o n tro ls (n 5 1 4 ) we re in v e s tig a te d . F o r a c o mp a ra tiv e a n a ly s is
o f in filtra tin g immu n e c e lls , a n e x t-g e n e ra tio n tis s u e mic ro a rra y o f b io p s ie s wa s a s s e mb le d ,
immu n o s ta in e d , a n d s c o re d . T a rg e te d tra n s c rip tio n a l p ro filin g wa s p e rfo rme d u s in g a c u s to miz e d
immu n o lo g y p a n e l.
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RESULTS: In J P , a p re d o min a n t a c c u mu la tio n o f n e u tro p h ils a n d e o s in o p h ils wa s o b s e rve d .RNA e xp re s sio n p ro file s
re v e a le d in c re a s e d le v e ls o f CXCL8, CXCL5, a n d CCL11 tra n s c rip ts in J P , in d ic a tin g a n e n h a n c e d
re c ru itme n t o f n e u tro p h ils a n d e o s in o p h ils . Mo re o ve r, me s se n g e r RNA le v e ls o f th e p ro in fla mma to ry
c yto k in e IL1b a n d th e in fla mma tio n -amp lifyin g re c e p to rTREM1we re h ig h e r in J P , wh e re a s we c o u ld n o t
fin d s ig n s o f a fu n c tio n a lly p o la rize d T c e ll re s p o n s e in J P wh e n c omp a re d with IBD.
DISCUSSION: P a tie n ts with J P a n d p a tie n ts with tre a tme n t-n a ı̈v e IBD h a v e d is tin c t c e ll in filtra te s d u rin g a c tiv e
d is e a s e . T h e a mp le p re s e n c e o f e o s in o p h ils in J P s u p p o rts n e u tro p h il a c c u mu la tio n , wh ic h is
re s p o n s ib le fo r th e e le v a te d re le a s e o f c a lp ro te c tin . In trig u in g ly , h o we v e r, we we re n o t a b le to id e n tify a
fu n c tio n a lly p o la riz e d T -c e ll re s p o n s e in J P , wh ic h in d ic a te s th a t d u rin g th e a c u te o n s e t o f
in fla mma tio n in J P , a p o te n t a d a p tiv e immu n e memo ry is n o t e s ta b lis h e d . T h is ma y e x p la in th e lo w
re o c c u rre n c e ra te o f J P .
SUPPLEMENTARY MATERIAL accompanies this paperathttp://links.lww.com/CTG/A620,http://links.lww.com/CTG/A621,http://links.lww.com/CTG/A622,http://
links.lww.com/CTG/A623,http://links.lww.com/CTG/A624
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INT RODUC T ION
Juvenile polyps (JPs) are the most common colonic polyp in
children and considered a benign entity (1,2).Epidemiological
data are scarce;however,in up to 12% ofpediatric patientswho
undergo colonoscopy because ofhematochezia,a JP isidentified
as source ofbleeding (3).JP seldom reoccurs after spontaneous
dispatch or endoscopic removal(4).By contrast,inflammatory
boweldisease (IBD)is a chronic relapsing inflammatory disease
of the intestine.The etiology of IBD is multifactorial,and evi-
dence suggests a disrupted interplay between hostimmune sys-
tem and environmental factors at multiple levels (5). It is
generally believed thatIBD develops in genetically predisposed
individualsbecauseofaberrantimmuneresponsesoftheadaptive
and the innate immune system in reaction to luminalantigens.
Fecal calprotectin,a heterodimeric protein with the subunits
S100A8 and A9 (also known as myeloid-related protein 8/14,
MRP8/14),isan acceptedstoolmarkerformucosalinflammationin
IBD in adultsand children (6)and isalso elevated in JP (7–9).The
main cellular source ofcalprotectin is neutrophils (10).In histo-
logical examinations,JP show high numbers of neutrophils (7).
However,the underlying mechanisms leading to the neutrophil-
driven immune response in JP are notwell-described.JP and IBD
both show localepithelialdefects.The impaired barrier function
with increased exposure to potentially inflammatory stimuli(11)
may suggesta similarimmune response in both entities.
Transcriptome analysis of adult IBD and control tissue
revealed differentexpression levelsofmolecules involved in im-
mune regulation and response between IBD and controlsaswell
as between IBD subtypes (12,13).This observation allowed to
deduce pathogenesisfactorsofthe disease,such asa polarized T
helper 2 (Th2) vs T helper 1 (Th1) immune response for ulcer-
ativecolitis(UC)andCrohn’sdisease(CD),respectively (13).We
therefore aimed to uncover differences in the gene expression
profiles in the affected colonic mucosa of patients with JP vs
patients with pediatric IBD and noninflammatory (non-IBD)
controls.Based on the histologicalfindings,we decided to per-
form a targeted transcriptionalapproach to analyze the interac-
tionsbetween differentimmune cellsubtypes.
We hypothesize that an inflammatory microenvironment,
which supports innate immune responses is critical for the
development and maintenance of JP.By contrast, the strong,
functionally polarized activation of the adaptive immune re-
sponse,notably ofTcellsubsets(14),leadsto theestablishmentof
a chronic inflammation in IBD.
Weanalyze the inflammatory infiltrate ofJP,treatment-näıve
IBD patientsamples withoutdrug-related alterations in the in-
flammatory responseand non-IBDcontrols(15).Wewereableto
conclusively compare the immune microenvironment in JP in
comparison with IBD and non-IBD controls.Furthermore,we
providenovelinsightsinto theinvolvementoftheinnateimmune
system in thepathology ofJP and theexclusiveroleofeosinophils
as supporters ofneutrophilexpansion.Collectively,the benign
feature and high levelsofcalprotectin ofJP may be explained by
thelack oftheestablishmentofa functionalTcellmemory and the
predominantneutrophilaccumulation.
ME T HODS
C o h o rt a n d S a mp le s
Sixty-seven biopsies from 12 JP,14 non-IBD controls,and 41
patientswith treatment-näıve pediatric IBD (18 CD and 23 UC)
who underwent diagnostic colonoscopy at the Children’s Hos-
pital,Lucerne,oratthe Children’sHospital,Bern,between 2007
and 2013 were retrieved.Patients with more than 1 polyp or
polyposissyndromeswereexcluded.IBD diagnosiswasbased on
the revised Porto criteria (16).For patients with IBD,biopsies
from the most inflamed area were used.For CD,only patients
with histological activity in colonic biopsies were considered
because ofthe known site-specific differencesin the composition
ofimmunecellsin theterminalileum and colon (17).Ascontrols,
biopsieswere used from pediatric patients,where IBD wasruled
out based on findings of macroscopically and microscopically
normalmucosa (further referred as “non-IBD”).Main indica-
tions for colonoscopy in patients with non-IBD were rectal
bleeding, recurrent abdominal pain, or diarrhea. The definite
diagnosisin these patientswasfunctionalgastrointestinaldisor-
ders,including obstipation,irritable bowelsyndrome,and func-
tionalabdominalpain.
Clinicaldata taken as part ofclinicalroutine were collected
from patients’ charts, including sex, age at diagnosis, rectal
bleeding atfirstpresentation,disease location,and activity scores








(Pediatric Crohn’sDisease Activity Index (18);Pediatric Ulcer-
ative Colitis Activity Index (19)) for patients with IBD at di-
agnosisand laboratory workup atdiagnosis.
TheEthicsCommitteeofBern granted ethicalapproval(KEK-
BE:200/2014).
Ne x t-g e n e ra tio n tis s u e mic ro a rra y
Hematoxylin and eosin (H&E)slideswere retrieved from the di-
agnostic archive and scanned using slide scanner (3DHistech,
Budapest,Hungary).Then,each wholeslideimage corresponding
to polyps and colonic mucosa ofpatientswith non-IBD and IBD
wasdigitally annotatedusing a tissuemicroarray annotation toolof
0.6 mm in diameterin 5 representative tissue areas.One area was
annotated to representa tissuepunch forembeddinginto thetissue
microarray and the remaining areas for subsequent molecular
analysis.Annotated scanswerealigned to thecorresponding tissue
blocks in an automated tissue microarrayer (Grand Master;
3DHistech, Budapest,Hungary), and corresponding regions of
interest were punched out.One punch was transferred into re-
cipientnext-generationTissueMicroarray (ngTMA)block and the
remaining punches into Eppendorf tubes for subsequent RNA
extraction.Generating ngTMA allowed serialstaining ofalltissue
samples forH&E and immunohistochemistry (20).The ngTMA
block was sectioned at4 mm,and after deparaffinization and re-
hydration,standardH&Eandimmunohistochemistrystainingwas
performed (see Supplementary Table 1, http://links.lww.com
/CTG/A624).A pathologist(M.M.),blinded to the diagnosis and
clinicaldata,reviewed and scored allhistology slides.
H&E stainings were scored for inflammatory activity on a 3-
point-scale (1 5 none/mild, 2 5 moderate, and 3 5 severe)
according to the activity definition used in the PAID (pattern,
activity,interpretation,dysplasia)scheme (21).The inflammatory
infiltrateasa wholewasused asa nominatorand theabundanceof
thesingle-celltypesasa numeratortocharacterizethecomposition
oftheinflammatory infiltrate.Theproportion ofeosinophilsofthe
inflammatory infiltrate was determined on H&E slides.For neu-
trophils,T cells,B cells, and plasma cells, the appropriate cell
markers myeloperoxidase (MPO),CD3,CD20,and CD138,re-
spectively,were analyzed on serialngTMA sections.Cellcounting
per punch was performed for T-regulatory cells (FoxP3) and ac-
tivated T cells (CD30) because of their low abundance.Macro-
phage (CD68) density ofthe punch was scored as 1 5 low,2 5
moderate,and 35 high.Costainingsofthedescribedmarkerswith
the subunit S100A8 ofcalprotectin allowed us to determine the
cellularsource ofcalprotectin.
Na n o s trin g a n a ly s is
TotalRNA from 3 punches from biopsies of each patient was
purified with a column-based approach as described by Oberli
etal.(22)RNA concentration wasdetermined by measuring the
260 nm absorbance on a NanoDrop One (Thermo Scientific,
Waltham,MA),and 100 ng ofeach RNA sample was used for
transcriptional profiling using a custom designed nCounter
PlexSet (nanostring,Seattle,WA) (see Supplementary Table 2,
http://links.lww.com/CTG/A624).
S ta tis tic a l a n a ly s is
Foralldata,the Studentttest,Wilcoxon rank sum test,orx2 test
wereused asindicated.NanoString Raw countswerenormalized
using the R package NanoStringNorm.Normalized countswere
log-transferred,and the differentialgene expression analysiswas
performed using the edgeR package. Each patient group was
compared with each other individually.P values were adjusted
according to theBenjamini-Hochberg correction test.P values,
0.05wereconsidered to bestatistically significant.PCanalysiswas
performed inR (statspackage),and datawerevisualized using the
ggplot2 package. Heat map of the gene expression data was
generated using the Morpheus app (https://software.broad-
institute.org/morpheus),using 1 minus Pearson correlation for
both,columnsand rows.Data were analyzed using R v3.5.0.
RE S UL T S
In itia l c lin ic a l a n d la b o ra to ry p re s e n ta tio n in p a tie n ts with J P
a re n o n s p e c ific
Wefound thatmostJP presented with signsofrectalbleeding as
the leading symptom (Table 1),which wasalso true fornon-IBD
controls and patients with UC.Systemic inflammatory markers
such as hemoglobin,thrombocytes,erythrocyte sedimentation
rate,C-reactiveprotein,and albumin werevariableandmostly in
normalrange in our patients with JP and UC.By contrast,pa-
tientswithCDhad an increasein systemicinflammatorymarkers
and decreased hemoglobin and albumin values.
Fecal calprotectin levels were available from 33 patients at
diagnosis;however,becauseofdifferent(lateralflow and enzyme-
linked immunosorbent assay-based) laboratory assays used in
ourcohort,theindicated levelswerenotdirectly comparable.The
levels ranged from 25 to 277 mg/kg in 4 non-IBD controls,
110–934 mg/kg in 7 patients with JP,101–5,432 mg/kg in 15
patientswithUC,and 473–3,000mg/kg in 8 patientswith CD.As
thecutoffwas50 mg/kg in allassays,allpatientswith JP and IBD
had per definition raised levels.None of non-IBD controls,3
patientswith JP,13 patientswithUC,and 8 patientswith CD had
calprotectin values. 103 ULN.
n g T MA a n a ly s is re v e a ls a p ro n o u n c e d a c c u mu la tio n o f
n e u tro p h ils a n d e o s in o p h ils in J P
Because we were interested in factorssupporting localinfiltration
and survivalofinflammatory cells,weidentified themostinflamed
mucosaltissue sections in patients with IBD for further analysis
(Figure 1a).The cellular composition ofthe inflammatory infil-
trates is substantially differentbetween patients with JP and pa-
tients with IBD at the site of maximum histopathological
inflammatory activity.InpatientswithJP,wedetected a prominent
infiltration by neutrophils and eosinophils,whereas in patients
with IBD,thecellularinfiltratesweredominated by T cells,plasma
cells,and B cells(Figure 1a,b;see Supplementary Figure 1,http://
links.lww.com/CTG/A620).There was no difference in the pres-
ence ofeosinophilsbetween CD and UC.Furthermore,we found
CD681 macrophages at comparable frequencies in all tissue
samples(seeSupplementary Figures1,http://links.lww.com/CTG/
A620 and 2,http://links.lww.com/CTG/A621).
Next,we defined the cellular source of calprotectin by per-
forming costaining ofcalprotectin and inflammatory cellmark-
ers.Calprotectin reactivity was most often associated with the
presence ofneutrophils (MPO1);however,there was no differ-
encein thefrequency ofcalprotectin1neutrophilsbetween theJP
and IBD groups (Figure 1c,d). In addition, macrophages
expressed calprotectin (23),however,to amuch lesserextentthan
neutrophils(Figure 1d;see Supplementary Figure 1,http://links.
lww.com/CTG/A620). No coexpression was seen for T cells,
B cells,eosinophils,epithelial,and endothelialcells.
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Different Tcellsubsets are known to trigger and perpetuate
intestinaldamage,including t-bet(TBX21)-expressing Th1 cells,
which supportproinflammatory cell-mediated immunereactions
andCD301 andGATA3-expressing Th2 cells,whereby thelatter
produce eosinophil-activating cytokines,such as IL-5 and IL-13
(24).In non-IBD controls,no CD301 cellswerespotted and only
a few FoxP31 regulatory T cells (Tregs),whereas all3 disease
groups (JP,UC,and CD)showed similarnumbers ofthese cells
(see Supplementary Figure 3,http://links.lww.com/CTG/A622).
Collectively,histologicalanalysisshowed thatJP hasa distinct
inflammatory infiltrate,which consistsmainly ofneutrophilsand
eosinophils,whereas in pediatric IBD,cells ofthe adaptive im-
mune cellsdominate (T cells,B cells,and plasma cells).Neutro-
phils and,to a much lesser extent,macrophages were the sole
source ofcalprotectin.
T ra n s c rip tio n a l p ro filin g re v e a ls d is e a s e -s p e c ific a lte ra tio n in J P
c o mp a re d with C D a n d UC
In addition,we aimed to determine whether distinctcellular in-
flammatory infiltrates in JP and IBD can be attributed to a dif-
ferentialexpression ofchemokinesand cytokines.To thisend,we
isolated totalRNA from tissue punches ofallpatients and non-
IBD controls for gene expression analysis.To decipher the mo-
lecular pathways involved in the maintenance ofinflammation,
weselected themostinflammed areasoftissue,which resulted in
similar inflammation scores based on histopathologicalevalua-
tion (see Supplementary Figure 4, http://links.lww.com/CTG/
A623).
The transcriptionalprofiling wasperformed using a custom-
designed NanoString PlexSet consisting of a panelof 40 genes
involved in immune pathways (see Supplementary Table 2,
http://links.lww.com/CTG/A624).Theselection ofthe geneswas
based on thehistopathologicalassessmentin a targeted approach
to identify underlying pathogeneticmechanisms.We excluded 4
genes (MPO,IL17F,IL23A,and TREM2) from the analysis be-
cause theirexpression wasbelow the detection limit.In contrast
to thehistologicalevaluation,wecould notdetectany substantial
messengerRNA(mRNA)levelsofMPO.Thismightbedueto the
fact thatMPO is mainly produced during maturation of neu-
trophilsand stored in azurophilicgranulesinmatureneutrophils
(25).Principalcomponent(PC) analysis revealed a clear differ-
ence in the transcriptional profile between JP and non-IBD
controlgroup.TheIBD subtypegroups,UC and CD,clustered in
between the JP and the non-IBD controlgroup (Figure 2a).Hi-
erarchicalclustering analysisofthecompletedatasetclustered the
JP group in line with the PC analysis separately compared with
the non-IBD controland the IBD group (Figure 2b).Significant
gene expression differences were found between JP vs non-IBD
T a b le 1 . Ba s e lin e c h a ra c te ris tic s o f s tu d y c o h o rt
No n -IBD c o n tro l J P C D UC
N (male) 14 (7) 12 (7) 18 (13) 23 (11)
Age,yr,mean (SD) 7.72 (4.93) 5.83 (3.72) 9.6 (3.47) 10.16 (3.88)
Rectalbleeding atfirstpresentation,n (%) 9 (64) 10 (83) 7 (39) 17 (74)
PCDAIscore atdiagnosis,n,10 to 30 mild:
.30 moderate/severe
6:12
PUCAIscore atdiagnosis,n,10 to,30 mild:
30 to,65 moderate:.65 severe
3:18:2
Parisclassification atdiagnosis,n (%)











Hemoglobin,g/L 128.2 (9.0) 123.5 (13.3) 107.1 (14.8) 109.7 (20.3)
Thrombocytes,g/L 376.6 (83.8) 327.4 (84.0) 481.2 (107.7) 400.8 (101.2)
C-reactive protein,mg/dL 1 (0) 10.6 (27.3) 32.6 (14.7) 14.7 (25.4)
Erythrocyte sedimentation rate,mm/hr 10 (2.8) 10.1 (6.4) 47.5 (35.9) 21.1 (14.2)
Albumin,g/L 40.3 (2.5) 39.3 (2.1) 30.3 (5.0) 36.1 (6.6)
CD,Crohn’sdisease;JP,juvenile polyps;IBD,inflammatoryboweldisease;PCDAI,Pediatric Crohn’sDisease ActivityIndex;PCUAI,Pediatric Ulcerative ColitisActivity
Index;UC,ulcerative colitis.








controlgroup,JP and CD,and JP and UC in 55.6% (20 genes),
58.3% (21 genes),and 52.8% (19 genes),respectively.There was
no significant change between patients with treatment-näıve
pediatric CD and patients with UC besides a trend toward an
increased mRNA expression of IL17A in UC patient samples.
Mainly, genes encoding cytokines and chemokines which are
involved in theregulation ofrecruitment,activation,and survival
of neutrophils,such as CXCL8 (26),colony-stimulating factor
(CSF) 2,CSF3 (27),CXCL5 (28) (Figure 3a),and eosinophils
(CCL11 and CCR3)(Figure 3b)were upregulated in JP.Because
CCR3 is also expressed on Th2 cells (29),a preferentialshiftto
localTh2 celldifferentiation in JP compared with IBD cannotbe
excluded. Indeed, the IBD group tends to have higher ratio
(TBX21/GATA3) of transcripts levels toward the Th1 cell-
F ig u re 1 . (a )Representative ngTMA H&E staining’sofnon-IBD controls(non-IBD ctrl),solitaryJP,CD,and UC tissue samples.(b )Calprotectin (red)and
MPO (brown)costaining.(a –b )Representativemicrographsat203 and 403magnification.Barsindicate100 and 50mm,respectively.Arrowheadsshow
examplesofcalprotectin and MPO double-positive cells.(c )Cellularcomposition ofinflammatoryinfiltrates.Relative abundance ofB cells,eosinophils,
neutrophils,plasmacells,and Tcellsin the indicated groups.(d )Relative frequencyofeithercalprotectin positive neutrophilsormacrophageswithin the
indicated groups.CD,Crohn’sdisease;JP,juvenile polyps;IBD,inflammatoryboweldisease;MPO,myeloperoxidase;UC,ulcerative colitis







Microenvironmentin Solitary JP 5
specific transcription factorTBX21 compared with JP and non-
IBD control(Figure 3c).
Next, we analyzed the transcriptional profile of proin-
flammatorymarkers.In theselected regions,wefound high levels
of calprotectin transcripts (S100A8/A9) with significantly in-
creased expression in JP samples (Figure 3d).As expected,the
inflammatory profilesofJP tend to exhibitamostly innate-driven
proinflammatory gene expression profile, notably, increased
transcriptlevelsofthe IL1ß and TREM1 genes.By contrast,UC
and CD preferably display a preferentialupregulation ofmRNA’s
generally associated with a preferentialTh1 CD4 Tcelldifferen-
tiation,including IFNg and the IFNg inducible gene CXCL10/
IP10,which encodesthe ligand forCXCR3 (Figure 3e).
The mononuclear phagocyte system represents a major reg-
ulator of the local tissue homeostasis in the intestinal lamina
propria. Hence, we also examined the transcriptional profile
targeting the mononuclear phagocyte system, particularly,
monocytesand macrophages.In linewith the histology data,the
totalpresenceofmacrophagesdoesnotseem to bealtered in JP vs
pediatric IBD based on CD68 transcription levelbetween groups
(Figure 3f).Interestingly,the JP group seems to have a reduced
influx ofCCR21 monocytes but increased CSF2/GM-CSF ex-
pression,which critically supports survival, proliferation, and
differentiation ofmyeloid cellsduring injury (30).
Together these results reveal a distinct gene expression profile
betweenJPandIBDbiopsiesbutalsobetweenJPandnon-IBDcontrol
biopsies.Theaforementioned geneexpression profilesarein linewith
thefindingsbyimmunohistochemistry andsupportthenotionthatin
JP,theenhanced recruitment,activation,and survivalofneutrophils,
and eosinophils critically contribute to the pathogenesis,whereas in
pediatric IBD components ofthe adaptive Tcellresponse,notably,
IFNg and CCXL10/IP10 are prominently expressed.
F ig u re 2 .(a )PC analysisofnon-IBDcontrolsvssolitaryJP vsIBD,includingCDandUC ofthelog2-transformed countspermillion (CPM)oftheNanoString
gene expression analysisand (b )heatmap ofthe log2-transformed CPM,including k meansclustering ofallgenesanalyzed.CD,Crohn’s disease;JP,
juvenile polyps;IBD,inflammatoryboweldisease;UC,ulcerative colitis.








DIS C US S ION
In pediatric practice,JP symptoms are nonspecific and can re-
semble IBD, especially UC, at initial presentation with raised
calprotectin and rectalbleeding.JP isan inflammatory condition
thatdoesnotusually reoccur,whereasIBD isa chronic relapsing
inflammatory disease ofthe intestine.
Toshed lighton thepathogenesisofJP,wefirstdetermined the
composition of the inflammatory infiltrate and the source of
calprotectin in intestinaltissue samples.JP tissue shows a pre-
dominant accumulation ofinnate immune cells,dominated by
neutrophils and eosinophils. Immunohistological costaining
identified neutrophils and macrophages asmain sources ofcal-
protectin.Previously,it was documented that colonic biopsies
from areasadjacentto JP have normalmucosa (31).Thus,other
relevantregionalsourcesofcalprotectin in JP are unlikely,and a
solitary JP alone explains the high calprotectin found in stool
samples ofJP.Fecalcalprotectin in JP can be even as high as in
IBD.In IBD,however,affectedmucosalarea isoften substantially
larger,which can explain a cumulative higher leveloffecalcal-
protectin despite a lowerlocaldensity ofneutrophils.In linewith
this assumption,the mRNA expression ofS100A8/A9,the sub-
units of calprotectin,were significantly higher in JP than IBD
tissuesamplesin ourcohort.Theexcessiveexpression ofS100A8/
A9 in JP in comparison with IBD may be one reason for the
neutrophil rich infiltrate in JP because S100A8/A9 exhibits
chemotacticfunction and enhancesleukocyterecruitment(32)as
wellasexhibits an antiapoptotic effecton neutrophils(33).
To obtain furtherinsightinto themechanismsthatlead to the
preferentialaccumulation ofneutrophilsand eosinophilsin JP,we
selectively looked for factors known to promote the recruitment,
activation,and survivalofthese 2 celltypes.CXCL8/IL-8,a che-
mokinesupporting neutrophilmigration,waspreviously reported
to be elevated in inflamed tissue ofpatientswith IBD (26,34).In
addition,in ourcohort,the pediatric IBD samplesshowed signif-
icantly increased CXCL8 mRNA levels in comparison with non-
IBD controlsamples.More interestingly,CXCL8 mRNA levelsin
JP significantly exceeded thelevelsin IBD.Hence,wecan speculate
thatJP reflectsan acuteand transienteventin an otherwisehealthy
environmentand thatthehigh neutrophilinfluxmay even prevent
chronicity by avoiding or suppressing the recruitment and acti-
vation of adaptive immune cells.The cascade leading to the es-
tablishmentofa localadaptive immune cellmemory—and to an
enhanced risk ofrelapsing disease—isinterrupted.
Furthermore,wefound significantly increased levelsofTREM-
1 and IL-1ß mRNAs in JP.TREM-1 ismainly expressed by neu-
trophils and inflammatory macrophages and amplifies the
production ofproinflammatorymediators,including CXCL8 (35).
Hence,theactivation ofTREM-1may help to sustain a neutrophil-
driven inflammation in JP.IL1ß isknown to beexpressed notonly
by macrophages and neutrophils but also by gastrointestinal
F ig u re 3 .(a –f)NanoStringGeneexpression analysisofnon-IBDcontrols,solitaryJP,CD,andUC tissuesamples.Boxandwhiskersarerepresentativeofthe
log2-transformedCPMgeneexpression valuesoftheindicatedgroups.#IndicatestheadjustedP-valueoftheindicatedgroupsin comparisonwiththenon-
IBDcontrolgroup.*IndicatestheadjustedP-valueamongJP,CD,andUC groupswith*/#P,0.05,**/##P,0.01,***/###P,0.001,and****/####P,
0.0001.No indication meansP. 0.05 and isconsidered notsignificant.CD,Crohn’sdisease;JP,juvenile polyps;IBD,inflammatoryboweldisease;UC,
ulcerative colitis.
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eosinophils(36).Thus,in JP,theaccumulation ofeosinophilsmay
contribute to the observed high level of IL1ß and thereby also
supportneutrophilinflux and survival(37).
Eosinophilswere detected in high frequencies in JP based on
histochemicalevaluation and indirectly by the detection of in-
creased CCR3 transcriptlevels.In line with thisobservation,we
also detected high levels ofCCL11 transcripts,which indicates
enhanced recruitmentofeosinophils in JP compared with IBD.
The exactrole ofeosinophils in the pathogenesis ofJP is so far
unknown and issubjectoffurtherinvestigations;however,wecan
assumethateosinophilsmightsupportan enhanced recruitment
ofneutrophilsthrough the production ofCXCL5/ENA78 (38).
We also saw a significant increased CSF2/GM-CSF mRNA
expression in JP compared with theothergroups.CSF2 supports
macrophages differentiation butalso eosinophiland neutrophil
survival(30).More importantly,the high levels of CSF2 tran-
scriptsin JPmay also help restoreimmunehemostasisby limiting
the activation of the adaptive immune response through the
regulation ofantigen presenting cellsand theirinteractionswith
T cells (30).The low mRNA expression of IFNg and CXCL10
indicatesonlymoderateT-cellrecruitmentand Th1 priming (39)
in JP compared with IBD.Hence,ourdata indicatethatJP can be
characterized as an isolated event with a predominant re-
cruitment and activation ofneutrophils and eosinophils in the
absence ofan adaptive localTh1 response.
Based on the immunohistochemical evaluation and the
NanoString analysis,no difference in the frequency ofCD681
macrophageswasobserved.On a transcriptionallevel,however,
wedetected reduced levelsofCCR2 transcriptsin JPbiopsies.This
observation argues that in JP only limited proinflammatory
CCR21monocytesare recruited and thatthe constantpresence
ofmainly residentintestinalmacrophagesmay resultin a highly
attenuated priming and expansion of CD4 T cells (40). In-
triguingly, tissue-resident CD4 T cells were characteristically
observed in IBD and identified as criticalmediatorsofrelapsing
inflammatory disease (41).Our findings may explain the tran-
sientnature ofthe localinflammation in JP withoutprogression
toward a chronic relapsing disease.However, to gain a more
completeunderstanding oftheexactunderlying differencesin the
immunologicalmechanisms operative in the pathogenesis ofJP
vs IBD,future studies willbe required to directly confirm the
absenceofa functionally polarized,tissue-residentadaptiveTcell
memory in JP,asindicated by ourresults.
In conclusion,we elucidate the inflammatory infiltrate in JP
tissue with its unique expression of genes involved in the re-
cruitment (S100A8/A9,CXCL8),activation (TREM1,CXCL5/
ENA78),and survival(CSF2)ofthe innate immune cellsubsets.
Fortheclinician,itisreassuring thatthelimited expansion ofthe
strong butspatially highly restricted site ofinflammation in JP
may be sufficient to cause a raise in calprotectin and rectal
bleeding.This occurs withoutthe formation ofa localadaptive
immunological memory, which may be a prerequisite for a
chronic relapsing inflammatory disease,such as IBD.Further-
more,the benign etiology ofJP can be explained by the compo-
sition ofthespecificimmuneinfiltrate,and hence,emerging stool
markers reflecting the inflammatory response may distinguish
between JP and IBDbeforeproceeding to colonoscopy in thenear
future.
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S tu d y Hig h lig h ts
WHA T IS KNOWN
3 Solitaryjuvenile polyps(JPs)are benign butpresentwith
obvioussignsofintestinalinflammation.
WHA T IS NE W HE RE
3 The immunologicalmicroenvironmentin JP ischaracterized
byan innate immune cellsignature.
3 No evidence fora functionallypolarized T-cellresponse is
seen in JP asischaracteristicforinflammatoryboweldisease.
T RA NS L A T IONA L IMP A C T
3 The observed immune responsemayexplain the benign
feature and low-recurrence rate ofJP.
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